← All trials
NCT01817699
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2013
- Primary completion
- Dec 31, 2018
- Completion date
- Dec 31, 2018
- First posted
- Mar 25, 2013
- Last posted
- Feb 4, 2019
- Enrollment
- 161
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- CANDLE-KIT Trial Study GroupLead sponsor
- ChugaiCollaborator
- RocheCollaborator
- Osaka UniversityOfficial
- The Japan Kidney FoundationCollaborator
- Japan Society for the Promotion of ScienceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.